Around 25,000 people die in the European Union each year from infections resistant to antibiotics. Third-generation cephalosporins are often useless against common bacteria like Escherichia coli, and fluoroquinolones are no longer the treatment of choice for gonorrhoea because resistance has become widespread. Here, you can find news stories and articles about the issue.
The number of new antibiotics in development is insufficient to mitigate the growing threat of antimicrobial resistance (AMR), according to a report launched by the World Health Organization (WHO).
The European Medicines Agency (EMA) is to host a summit meeting with doctors’ and patients’ organisations, academics, EU member states and the World Health Organization (WHO) to discuss how collaboration can help tackle antimicrobial resistance (AMR).
The Royal Pharmaceutical Society (RPS) has launched a major new campaign calling on all pharmacists to play a greater role in safeguarding antibiotics and minimising the spread of antimicrobial resistance.
The Royal Pharmaceutical Society (RPS) has published a new quick reference guide (QRG) to antimicrobial stewardship.
Fluoroquinolones for treating tuberculosisSubscription
Tuberculosis (TB) remains a significant global health and socioeconomic challenge. The duration of current anti-TB therapies, the adverse effects of certain anti-TB drugs and the growing problem of drug-resistant TB on an international scale mean that it is imperative for new, effective and safe treatment regimens to be developed. Fluoroquinolones are a class of drugs that have been used in the treatment of TB for several decades. This article provides an overview of the current treatment ...
There are around 12,000 cases of Clostridium difficile infection (CDI) each year in the UK and during 1999 to 2007, deaths from CDI peaked at around 4,000 per year. This article summarises diagnosis and management, as well as the current therapeutic options for CDI, including faecal microbiota transplant.
Science reproducibility crisis: better measurement is required to tackle global health challengesSubscription
Measurement underpins UK trade and regulation, and helps us support innovation and government policy.
Gram-positive bacteria are among the most common human pathogens associated with clinical infections, which range from mild skin infections to sepsis. In an era defined by antimicrobial resistance (AMR) and an increasing drive toward delivering patient care via ambulatory pathways, the paradigm for the management of infections is changing. Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), the best known cases of ...
We read with interest the article ’Pharmacist independent prescribers can make a significant contribution to antimicrobial stewardship’ by Hodson, Deslandes and Courtenay M (The Pharmaceutical Journal 2017;298:313).
The problem of dwindling treatment options for gonorrhoea is complicated because there are very few new antibiotics in development. Stewardship of our remaining antibiotic resources is now more urgent than ever.